Trials in Tampa, Florida
Here are the top 10 medical studies for prostate cancer in Tampa, Florida
Popular Filters
Phase 3 Trials
Antiandrogen
Apalutamide + Targeted Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Charleston, South Carolina
This trial is testing whether adding apalutamide to standard treatment, with or without targeted radiation therapy, helps patients with prostate cancer that has come back after treatment.
Radioisotope Therapy
Lu-177 PSMA Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Tampa, Florida
This trial is testing a radioactive treatment in patients with advanced prostate cancer that hasn't responded to other treatments. The treatment targets and kills cancer cells using radiation and has shown promising outcomes, including reduced disease progression and improved overall survival.
Trials With No Placebo
Antiandrogen
Apalutamide + Targeted Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Charleston, South Carolina
This trial is testing whether adding apalutamide to standard treatment, with or without targeted radiation therapy, helps patients with prostate cancer that has come back after treatment.
Monoclonal Antibodies
ONC-392 + Pembrolizumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Orlando, Florida
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Chemotherapy
Nivolumab + Docetaxel + ADT for Metastatic Prostate Cancer
Recruiting1 awardPhase 2
Tampa, Florida
This trial is studying a combination of ADT, chemotherapy, and immunotherapy to see if it is an effective treatment for hormone-sensitive prostate cancer that has spread to other parts of the body.
Checkpoint Inhibitor
Pembrolizumab for Prostate Cancer
Recruiting2 awardsPhase 2
Bay Pines, Florida
This trial is testing the efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer. The study will also compare the pre-treatment and at-progression metastatic tumor biopsies to investigate the molecular correlates of resistance and sensitivity to pembrolizumab.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.